Production of galactitol from galactose by the oleaginous yeast Rhodosporidium toruloides IFO0880 by Jagtap, Sujit Sadashiv et al.
Jagtap et al. Biotechnol Biofuels          (2019) 12:250  
https://doi.org/10.1186/s13068-019-1586-5
RESEARCH
Production of galactitol from galactose 
by the oleaginous yeast Rhodosporidium 
toruloides IFO0880
Sujit Sadashiv Jagtap1,3, Ashwini Ashok Bedekar1, Jing‑Jing Liu3, Yong‑Su Jin2,3 and Christopher V. Rao1,3*
Abstract 
Background: Sugar alcohols are commonly used as low‑calorie sweeteners and can serve as potential build‑
ing blocks for bio‑based chemicals. Previous work has shown that the oleaginous yeast Rhodosporidium toruloides 
IFO0880 can natively produce arabitol from xylose at relatively high titers, suggesting that it may be a useful host for 
sugar alcohol production. In this work, we explored whether R. toruloides can produce additional sugar alcohols.
Results: Rhodosporidium toruloides is able to produce galactitol from galactose. During growth in nitrogen‑rich 
medium, R. toruloides produced 3.2 ± 0.6 g/L, and 8.4 ± 0.8 g/L galactitol from 20 to 40 g/L galactose, respectively. In 
addition, R. toruloides was able to produce galactitol from galactose at reduced titers during growth in nitrogen‑poor 
medium, which also induces lipid production. These results suggest that R. toruloides can potentially be used for the 
co‑production of lipids and galactitol from galactose. We further characterized the mechanism for galactitol produc‑
tion, including identifying and biochemically characterizing the critical aldose reductase. Intracellular metabolite 
analysis was also performed to further understand galactose metabolism.
Conclusions: Rhodosporidium toruloides has traditionally been used for the production of lipids and lipid‑based 
chemicals. Our work demonstrates that R. toruloides can also produce galactitol, which can be used to produce poly‑
mers with applications in medicine and as a precursor for anti‑cancer drugs. Collectively, our results further establish 
that R. toruloides can produce multiple value‑added chemicals from a wide range of sugars.
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Background
Sugar alcohols are commonly used as low-calorie, natu-
ral sweeteners [1]. They have also been proposed by 
the Department of Energy as potential building blocks 
for bio-based chemicals [2]. Sugar alcohols are natu-
rally found in fruits, vegetables, and mushrooms [3]. In 
addition, they can be produced from sugars using yeast. 
Examples include arabitol, erythritol, mannitol, ribitol, 
and xylitol [4–10]. Production of these sugar alcohols 
by yeast often results, though not always, from redox 
imbalances associated with growth on different sugars [4, 
5]. The ability of yeast to naturally produce these sugar 
alcohols from simple sugars provides a potentially safer 
and more sustainable route than chemical ones based 
on hydrogenation [11]. Indeed, a number of sugar alco-
hols are industrially produced using yeast fermentations 
[12–15].
In this work, we investigated sugar alcohol production 
in Rhodosporidium toruloides IFO0880, a red basidiomy-
cete yeast. This yeast has been principally studied in the 
context of lipid-based chemical production, because it 
produces lipids at high titers during growth on a wide 
range of sugars [16–21]. In addition, it has been geneti-
cally engineered to produce carotenoids and terpenoids, 
indicating that R. toruloides can produce a wide range of 
value-added compounds [22–26].
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Recently, R. toruloides was also found to produce ara-
bitol, a five-carbon sugar alcohol from xylose, suggesting 
that it may be a promising host for sugar alcohol produc-
tion [5]. In particular, R. toruloides can grow on a wide 
range of sugars and can be cultured at high cell densi-
ties (> 100 g/L dry cell weight) in fermenters [17–19, 21, 
27–29]. In these regards, R. toruloides potentially enables 
a flexible production process where sugar alcohols and 
lipid-based chemicals can be coproduced.
Motivated by the previous arabitol finding, we tested 
whether R. toruloides is able to produce sugar alcohols 
from arabinose, cellobiose fructose, galactose, glucose, 
glycerol, mannose, or sucrose. Among the substrates 
tested, we observed sugar alcohol production only during 
growth on galactose, where the cells produced galactitol. 
We further characterized the pathway involved in galacti-
tol production and identified the critical aldol reductase. 
Galactitol, in addition to being a low-calorie sweetener, 
has also been used to produce polymers, with potential 
applications in drug delivery and tissue engineering [30–
32]. In addition, dianhydrogalactitol, a product of galac-
titol, can be used to treat a variety of cancers [33–36]. 
Collectively, this work suggests that R. toruloides can be 
used to produce this valuable sugar alcohol.
Results
Rhodosporidium toruloides produce galactitol 
during growth on galactose in nitrogen‑rich medium
To determine whether R. toruloides IFO0880 produces any 
sugar alcohols in addition to arabitol, we measured growth 
on arabinose, cellobiose, fructose, galactose, glucose, glyc-
erol, mannose, and sucrose in nitrogen-rich medium, the 
same based medium that induces arabitol production dur-
ing growth on xylose (Fig. 1). Cells were able to completely 
consume glucose, fructose, galactose, and mannose after 
48 h of shake flask growth. Likewise, cells were able to con-
sume almost 20 g/L sucrose, arabinose, and glycerol after 
72 h of shake flask growth. Growth on cellobiose was very 
slow as compared to the other sugars.
Only during growth on galactose did we observe poten-
tial sugar alcohol production as determined by high per-
formance liquid chromatography (HPLC). Analysis of 
the HPLC chromatogram indicated the presence of an 
additional metabolite produced by R. toruloides (Addi-
tional file  1: Figure S1). This metabolite was identified 
as d-galactitol by gas chromatography–mass spectrom-
etry (GC–MS) and proton nuclear magnetic resonance 
spectroscopy (1H-NMR) (Additional file 2: Figure S2 and 
Additional file 3: Figure S3).
We next measured the concentration of d-galactitol 
during growth of R. toruloides on galactose in nitrogen-
rich medium. d-galactitol was produced at all galac-
tose concentrations tested (Fig.  2). When the initial 
galactose concentration was 20 or 40 g/L, galactitol pro-
duction peaked at concentrations of 3.2 ± 0.6  g/L, and 
8.4 ± 0.8  g/L, respectively, after 120  h of growth. When 
the initial galactose concentration was 60 g/L, 8.2 ± 1 g/L 
of galactitol was produced after 96  h of growth. How-
ever, we found that the galactose was not completely 
consumed when the initial galactose concentration was 
60 g/L. This would explain why the galactitol titers were 
similar during growth on 40 g/L and 60 g/L galactose.
The maximum galactitol production rate and yield 
were 0.061  g/L/h and 0.22  g/g, respectively (Additional 
file  11: Table  S1). We observed maximal optical densi-
ties of 34.5 ± 2, 43.5 ± 2, and 53 ± 6 during growth on 
20, 40, and 60 g/L galactose, respectively. We also tested 
whether R. toruloides was able to consume galactitol dur-
ing growth in nitrogen-rich medium. No consumption 
was detected (Additional file 4: Figure S4).
Lipids and galactitol can be produced as co‑products
Oleaginous yeasts are routinely used as hosts for produc-
ing lipids from sugars. Lipid production in oleaginous 
yeast is induced by starving the cells of some essential 
nutrient, most commonly nitrogen. The results above 
demonstrate that R. toruloides can be used to produce 
galactitol. They also suggest that R. toruloides can be used 
to simultaneously produce lipids and galactitol, both val-
uable products. To test this hypothesis, we grew cells in 
nitrogen-poor medium with 20, 40, or 60 g/L galactose.
d-galactitol was produced during growth in nitrogen-
poor medium at the three galactose concentrations 
tested (Fig.  3). When the initial galactose concentra-
tion was 20 g/L, galactitol titers were 3.0 ± 0.3 g/L after 
144  h of growth. When the initial galactose concentra-
tions were 40 or 60 g/L, galactitol titers were 5.2 ± 0.5 g/L 
and 7.4 ± 0.8  g/L, respectively, after 144  h and 192  h of 
growth. However, we found that galactose was not com-
pletely consumed in nitrogen-poor medium when the 
initial galactose concentration was 40  g/L or 60  g/L. 
The maximum galactitol production rate and yield were 
0.028 g/L/h and 0.136 g/g, respectively, during growth in 
nitrogen-poor medium (Additional file 11: Table S1).
We also analyzed the lipid content and composition 
in cells grown on 40  g/L galactose in nitrogen-poor and 
nitrogen-rich medium. In nitrogen-poor medium, the 
final dry cell weight was 3.1 g/L and lipid content was 45% 
(Fig. 4a). In nitrogen-rich medium, the final dry cell weight 
was 10.5 g/L and lipid content was 5%. We also analyzed 
the composition of the lipid by fatty acid methyl ester anal-
ysis using GC–MS. The fatty acids were predominantly 
oleic (C18:1) and palmitic (C16:0) acid, with some stearic 
(C18:0) acid during growth on nitrogen-poor and nitro-
gen-rich medium (Fig.  4b). Similar compositions were 
observed during growth on glucose and xylose [5, 21].
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Rhodosporidium toruloides employs the Leloir pathway 
for galactose conversion
The Leloir pathway is employed for galactose utiliza-
tion by many yeast, including Saccharomyces cerevisiae, 
Kluyveromyces lactis, and Yarrowia lipolytica [37–40]. 
R. toruloides IFO0880  appears to possess the necessary 
genes for galactose conversion by the Leloir path-
way (Fig.  5). These genes were identified from the draft 
genome sequence of R. toruloides IFO0880 using the 
annotated genome for R. toruloides NP11 as the Refs. [21, 
29]. The associated gene identification numbers are pro-
vided below next to the associated enzymes.
Fig. 1 Growth of R. toruloides IFO0880 on different sugars at 20 g/L in nitrogen‑rich medium: a glucose, b fructose, c mannose, d sucrose, e 
arabinose, f glycerol, g cellobiose, and h galactose
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In the Leloir pathway, β-d-galactose is first converted to 
α-d-galactose by galactose mutarotase (GM, RTO4_8504). 
α-d-galactose is then phosphorylated to galactose-1-phos-
phate by galactokinase (GK, RTO4_13990). It then appears 
to be converted into galactitol by aldose reductase (AldR, 
RTO4_11553). In the form of galactose-1-phosphate, the 
galactose moiety is exchanged with the glucose group from 
UDP-glucose to generate UDP-galactose, simultaneously 
releasing glucose-1-phosphate by galactose-1-phosphate 
uridyl transferase (UT, RTO4_11332). Then, UDP-galactose 
is epimerized into UDP-glucose by UDP-glucose 4-epimer-
ase (EP, RTO4_8969). In the last step, glucose-1-phosphate 
is converted to glucose-6-phosphate by phosphogluco-
mutase (PGM, RTO4_9959). Glucose-6-phosphate then 
enters into glycolysis.
We examined the expression of the genes in the Lel-
oir pathway using quantitative PCR during growth in 
nitrogen-rich medium containing 2% glucose or 2% 
galactose (Fig.  6 and Additional file  11: Table  S2). All 
the genes were expressed during growth on galactose. 
Many were also expressed during growth on glucose, 
though the relative expression level was often lower. 
This would suggest that galactose gene expression is 
subject to glucose catabolite repression, similar to what 
is observed in S. cerevisiae  [41, 42]. However, the rela-
tive decrease in expression is not statistically significant 
due to variable levels of expression. Only in the case of 
aldose reductase (AldR) did we observe strong repres-
sion, as we were unable to detect expression during 
growth on glucose. In addition, we found that galac-
tose-1-phosphate uridyl transferase (UT) expression 
was higher during growth on glucose than on galactose, 
a result we cannot explain.
Fig. 2 Growth of R. toruloides IFO0880 on different concentrations of 
galactose in nitrogen‑rich medium: a 20 g/L of galactose, b 40 g/L of 
galactose, c 60 g/L of galactose
Fig. 3 Growth of R. toruloides IFO0880 on different concentrations of 
galactose in nitrogen‑poor medium: a 20 g/L of galactose, b 40 g/L of 
galactose, c 60 g/L of galactose
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Characterization of galactose reductase from R. toruloides
According to the proposed pathway (Fig.  5), an aldose 
reductase, AdhR, is directly involved in producing galac-
titol. We expressed and purified a codon-optimized ver-
sion of the enzyme in E. coli (Additional file 11: Table S3). 
AldR gene encodes a polypeptide 290 amino acids in 
length, with a calculated molecular mass of 32.4  kDa. 
The molecular weight of the recombinant enzyme was 
approximately 32  kDa, as determined by SDS-PAGE 
(Additional file  5: Figure S5). The recombinant enzyme 
exhibited activity against galactose with NADPH as the 
coenzyme; no activity was detected with NADH. Thus, 
AldR is an NADPH-dependent enzyme, like other galac-
tose reductases [43–45]. Next, we determined the opti-
mal pH and temperature for enzyme activity. These were 
found to be pH 7 and 25 °C (Additional file 6: Figure S6).
We next tested the relative activity of AldR on galactose, 
glucose, and xylose. AldR showed activity on galactose and 
xylose in the presence of NADPH as the coenzyme (Fig. 7). 
Among the tested substrates, AldR showed the highest activ-
ity on galactose. However, it also exhibited activity on xylose. 
AldR showed no activity on glucose. Recombinant AldR 
was then employed to produce galactitol from galactose. 
Authentic galactose and galactitol were used as controls, and 
the AldR reaction product was analyzed using HPLC. The 
product had the same retention time as galactitol (Additional 
file  7: Figure S7). In the control experiment without AldR 
enzyme, we did not observe galactitol production or galac-
tose consumption. Collectively, these results suggest that 
AldR is directly involved in galactitol production.
Analysis of intracellular metabolites
As far less is known about the growth of R. toruloides on 
galactose than on glucose, we compared the relative con-
centrations of 50 intracellular metabolites using GC–MS 
during exponential growth. Among the 50 metabolites 
analyzed, differences in the concentrations of 29 metab-
olites were observed during growth on galactose versus 
glucose (Fig.  8, Additional file  8: Figure S8, Additional 
file 11: Tables S4, S5).
We observed intracellular galactitol production when 
R. toruloides was grown on galactose. No intracellular 
galactitol production was observed during growth on 
glucose. (Additional file 9: Figure S9). We also observed 
decreased concentrations of the storage metabolite tre-
halose (0.5×), TCA intermediate citric acid (0.7×), and 
glycolytic intermediate glycerol 3-phosphate (0.8×) as 
compared to growth on glucose (Additional file 10: Fig-
ure S10). This is consistent with lower metabolic fluxes 
associated with galactose utilization. Aside from these 
more obvious changes, we also observed changes in 
many additional metabolites that elude simple explana-
tions. What these results do show is that galactose uti-
lization induces many changes to central metabolism as 
compared to glucose metabolism.
Discussion
Rhodosporidium toruloides IFO0880 is capable of grow-
ing on multiple sugars. Previous work found that R. toru-
loides produces d-arabitol during growth on xylose in 
nitrogen-rich medium [5]. In this study, we investigated 
whether R. toruloides produces any additional sugar 
alcohols. The key finding of the present study is that R. 
toruloides also produces galactitol at relatively high titers 
(> 8  g/L) during growth on galactose. As galactitol is a 
valuable product in its own right, these results indicate 
that R. toruloides can be used not only to produce lipid-
based chemicals but also this sugar alcohol as well.
Rhodosporidium toruloides produces galactitol in 
both nitrogen-rich and nitrogen-poor medium. In the 
Fig. 4 Intracellular lipid and FAME production by R. toruloides IFO0880 during growth in nitrogen‑poor and nitrogen‑rich medium with 40 g/L of 
galactose: a intracellular lipid content and dry cell weight for R. toruloides IFO0880. Solid diamonds and solid squares are used to denote dry cell 
weight of cells grown in nitrogen‑poor and nitrogen‑rich conditions, respectively. Solid inverted triangles and solid circles are used to denote lipid 
content of cells grown in nitrogen‑poor and nitrogen‑rich conditions, respectively. b Fatty acid composition as determined by GC–MS. Data show 
the mean and standard deviation resulting from two biological and two technical replicates
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previous d-arabitol study, arabitol was produced only 
during growth in nitrogen-rich medium [5]. During 
growth in nitrogen-poor medium, arabitol was not pro-
duced. Likely, this is because xylose was consumed very 
slowly in nitrogen-poor medium. These observations are 
consistent with d-arabitol being an overflow metabo-
lite associated with redox imbalances in the cell arising 
from high fluxes through the xylose metabolic pathway 
Fig. 5 Leloir pathway for galactose metabolism in R. toruloides IFO0880
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during growth in nitrogen-rich medium [4]. In the case 
of galactose metabolism, galactitol is also likely an over-
flow metabolite as more is produced when galactose 
utilization rates are high, for example during growth 
in nitrogen-rich medium. However, galactitol produc-
tion does not appear to be associated with any redox 
imbalances within the cell. More likely, it is produced 
to prevent the intracellular accumulation of galactose-
1-phosphate, a phosphorylated intermediate of the Leloir 
pathway (Fig.  5), which is toxic to the cell [44, 46]. The 
efficient utilization of galactose is limited by conversion 
of galactose-1-phosphate. Low expression of galactose-
1-phosphate uridylyltransferase likely causes a buildup 
of galactose-1-phosphate in the cell. One way to relieve 
this buildup would be to produce galactitol [47]. Such a 
mechanism would explain why R. toruloides produces 
galactitol.
Galactitol has been produced using chemical routes 
based on hydrogenation [11]. It has also been reported 
that is produced by several yeast during growth on galac-
tose [48, 49]. In one notable study, thirteen yeasts were 
screened for galactitol production using galactose as a 
sole carbon source [49]. Six were found to produce galac-
titol. The highest titers were obtained with Candida poly-
morpha, which produced 18.7 g/L galactitol from 110 g/L 
galactose. These titers are greater than those obtained 
with R. toruloides. However, the key advantage of using 
R. toruloides is that it can also co-produce other value-
added chemicals, in particular lipids and lipid-based 
chemicals. In addition to yeast, the bacterium Mycobac-
terium smegmatis was found to produce 7  g/L galacti-
tol from 10  g/L galactose and 10  g/L glucose [48]. This 
appears to be the only reported case of galactitol produc-
tion in bacteria.
In addition to native production, S. cerevisiae has also 
been engineered to produce galactitol. In one study, the 
aldose reductase in S. cerevisiae was overexpressed. The 
resulting strain produced 9 mg/L of galactitol from 5 g/L 
galactose [50]. In another study, S. cerevisiae strain EJ4 
was found to produce 0.40  g/L galactitol from 20  g/L 
galactose after 33  h of growth due to the promiscuous 
activities of heterologously expressed xylose reductase 
(XR) and xylitol dehydrogenase (XDH) [51]. This strain 
was also engineered to produce galactitol from lactose by 
deleting galactose kinase and heterologously expressing 
galactitol dehydrogenase [52]. It produced 3.5 g/L galac-
titol from 40 g/L of lactose, suggesting that lactose may 
also be a promising substrate for galactitol production.
Conclusions
Rhodosporidium toruloides has traditionally been viewed 
as a production host for lipids and lipid-based chemi-
cals. Our work demonstrates that this oleaginous yeast 
can also produce galactitol at high titers during growth 
on galactose. These results suggest that R. toruloides 
potentially enables a flexible production process that can 
account for different market conditions by producing a 
wide range of value-added chemicals from simple sugars.
Methods
Strains, media, and growth conditions
Rhodosporidium toruloides  IFO0880 was obtained from 
the NITE Biological Resource Center, Japan (NBRC 
0880). YPD medium (10  g/L yeast extract, 20  g/L pep-
tone, and 20  g/L glucose) was used for routine growth 
of R. toruloides. The two different media were tested 
Fig. 6 Expression profiles for galactose metabolic genes in R. 
toruloides IFO0880. Gene expression levels were normalized based 
on the expression of the actin gene. GM galactose mutarotase, AldR 
aldose reductase, GK galactokinase, UT galactose‑1‑phosphate uridyl 
transferase, EP UDP‑glucose 4‑epimerase, PGM glucose‑6‑phosphate 
by phosphoglucomutase
Fig. 7 Substrate specificity of aldose reductase (AldR) from R. 
toruloides IFO0880
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Fig. 8 Changes in metabolite concentrations during growth of R. toruloides IFO0880 on galactose (GAL) versus glucose (GLC). Metabolites with 
higher concentration during growth on galactose as shown in red and metabolites with higher concentrations during growth on glucose are 
shown in blue. Gal-1-P galactose‑1‑phosphate, UDP-glu UDP‑glucose, UDP-gal UDP‑galactose, Glu-1-P glucose‑1‑phosphate, G-6-P glucose 
6‑phosphate, F-6-P fructose 6‑phosphate, F-1,6-BP fructose 1,6‑bisphosphate, G-3-P glyceraldehyde 3‑phosphate, DHAP dihydroxyacetone 
phosphate, G-1,3-BP glycerate 1,3‑diphosphate, 3-PGA 3‑phospho‑d‑glycerate, 2-PGA 2‑phospho‑d‑glycerate, PEP phosphoenolpyruvate, Pyr 
pyruvate, AcCoA acetyl CoA, AKG alpha‑ketoglutarate, OAA oxaloacetate
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for galactitol production by R. toruloides: nitrogen-rich 
medium (10  g/L yeast extract and 20  g/L peptone) and 
nitrogen-poor medium [0.75  g/L yeast extract, 1.7  g/L 
yeast nitrogen base without amino acids and ammonium 
sulfate, 0.1 g/L  (NH4)2SO4, and pH 5.6]. Stationary phase 
seed cultures were obtained by inoculating single colo-
nies from YPD agar plate into 20 mL YPD liquid medium 
in 125  mL glass baffled shake flasks. The seed cultures 
were then used to inoculate 50  mL cultures in 250  mL 
glass baffled shake flasks with a starting  OD600 of 1. The 
cells were then grown at 30 °C and 250 rpm.
Determination of sugar and polyol concentrations
Sugar and galactitol concentrations were measured using 
a Shimadzu high-performance liquid chromatography 
(HPLC) system equipped with an RID-10A refractive 
index detector, an Aminex HPX-87H carbohydrate analy-
sis column (Bio-Rad Laboratories), and a cation H micro-
guard cartridge (Bio-Rad Laboratories). The column and 
guard cartridge were kept at 65 °C, and 5 mM  H2SO4 was 
used as a mobile phase at a constant flow rate of 0.6 mL/
min. Prior to analysis, culture samples were first pelleted 
and then the supernatant was passed through 0.22  μm 
polyethersulfone syringe filter. Peaks were identified and 
quantified by retention time comparison to authentic 
standards.
Galactose and galactitol peaks were also measured and 
confirmed by gas chromatography–mass spectrometry 
(GC–MS). 200 μL of sample was dried under vacuum and 
derivatized with 50 μL of methoxyamine hydrochloride 
(40 mg/mL in pyridine) for 60 min at 50 °C, then with 150 
μL of N-methyl-N-(trimethylsilyl)trifluoroacetamide plus 
1% of trimethylchlorosilane at 70 °C for 2 h, and follow-
ing 2 h incubation at room temperature. Chromatograms 
were acquired using a GC–MS system (Agilent) consist-
ing of an Agilent 7890 gas chromatograph, an Agilent 
5975 MSD and an HP 7683B autosampler. Gas chroma-
tography was performed on a ZB-5MS (60 m × 0.32 mm 
I.D. and 0.25 mm film thickness) capillary column (Phe-
nomenex). Inlet and MS interface temperatures were 
230  °C, and the ion source temperature was adjusted 
to 230  °C. An aliquot of 1  mL was injected with a split 
ratio of 40:1. Helium carrier gas was kept at a constant 
flow rate of 2.4 mL/min. The temperature program was: 
5  min isothermal heating at 70  °C, followed by an oven 
temperature increase of 5 °C per min to 310 °C and a final 
10  min at 310  °C. The mass spectrometer was operated 
in a positive electron impact mode at 69.9 eV ionization 
energy at m/z 50–800 scan range. The spectra of all chro-
matogram peaks were evaluated using the AMDIS 2.71 
(NIST) and authentic standards.
Galactitol peak was also confirmed by proton nuclear 
magnetic resonance (1H-NMR) spectroscopy. Cells were 
grown for 72  h on 40  g/L galactose in nitrogen-rich 
media and centrifuged at 16,000×g for 10  min. 600  μL 
of supernatant was mixed with 10% deuterium oxide. 
All 1D proton spectra were collected at 25 °C on an Agi-
lent 750  MHz VNMRS spectrometer equipped with a 
5  mm triple-resonance indirect detection probe with Z 
PFG gradient capability [11]. The standard 1D presatu-
ration pulse sequence was used, and water suppression 
was achieved with a low CW power irradiated at water 
resonance for 1.5  s. Each spectrum was collected with 
a 90° pulse angle of 10.5 ms, 32 scans and 2 s relaxation 
delay between scans. A solvent peak  (H2O) was used as 
the chemical shift reference. Mnova 14.0.1 (Mestrelab 
Research) was used for spectral processing and analy-
sis. Each spectrum was processed with 0.6 Hz line broad-
ening, 4 times zero-filling, auto-phase and auto-baseline 
correction.
Lipid and dry cell weight measurements
Lipids were also measured using the modified sulpho-
phospho-vanillin lipid assay [30, 53, 54]. The appropriate 
yeast suspension was centrifuged and then the cell pel-
let washed twice using sterile water. The washed cell pel-
let was mixed with 1 mL of 18 M sulfuric acid in a glass 
test tube and heated at 100 °C for 10 min in a dry heating 
bath. The reaction was cooled for 20 min in an ambient 
water bath. 2.5  mL of freshly prepared vanillin–phos-
phoric acid was added and reacted for 15 min at 37  °C. 
The test tube was cooled for 15  min in a water bath at 
ambient temperature. The absorbance of each reaction 
was measured at 530 nm against a reference sample pre-
pared in water using the Tecan Infinite M1000 Pro micro-
plate reader. Absorbance measurements were converted 
to lipid concentration using a calibration curve prepared 
using refined corn oil. Corn oil (100  mg) was dissolved 
in 2:1 chloroform:methanol (20 mL) and a stock solution 
was loaded into an assay mixture at 50–250 µg. A stand-
ard curve was run with each set. Vanillin–phosphoric 
acid solution was prepared freshly by dissolving 0.12  g 
vanillin in 20  mL  dH2O, and adjusting the volume to 
100 mL with 85% o-phosphoric acid. This assay was vali-
dated previously for various oleaginous yeast lipids, and 
common media ingredients were found to provide mini-
mal interference [30, 54].
Cell growth was measured by the optical absorbance 
at 600 nm  (OD600). Dry cell weights (DCW) were deter-
mined as follows. Culture samples (1 mL) were collected 
into pre-weighed tubes and centrifuged at 16,000×g for 
5  min. Supernatant was discarded. Pellets were then 
Page 10 of 13Jagtap et al. Biotechnol Biofuels          (2019) 12:250 
washed twice with 50  mM phosphate buffered saline. 
Washed pellets were dried to constant weight at 65 °C for 
24 to 48 h. The tubes were then weighed.
Measurement of fatty acid composition
Fatty acid compositions were determined by GC–MS. 
The fatty acids were first derivatized using the method 
of Lepage and Roy [55]. Briefly, lyophilized samples 
(1  mL) were first resuspended in 2  mL of a 20:1 mix-
ture of methanol and acetyl chloride solution and 2 mL 
of hexane. 25 mg/mL tridecanoic acid dissolved in a 3:2 
methanol:benzene mixture was then added (2.5 μL) as an 
internal standard. The mixture was then incubated in a 
dry bath at 100 °C for 30 min in a sealed glass tube with 
a screw cap. After cooling down in room temperature, 
1 mL water was added to induce phase separation. This 
process generates fatty acid methyl esters from all the 
lipid compounds. The upper organic phase containing 
the fatty acid methyl esters was collected for analysis by 
GC/MS. Samples (2 μL) were injected at a 0:1 split ratio 
using hexane as a solvent. Helium carrier gas was used 
at a pressure of 121.7 kPa and a flow rate of 1.0 mL/min. 
The injection port temperature was set at 250 °C. Column 
temperature started at 30 °C and increased to 250 °C at a 
rate of 10 °C/min. Eluent from the GC entered an ioniza-
tion chamber at 250 °C and was measured at a full scan 
between 15 and 250 amu. Species identity was verified by 
comparison of mass spectra to the analytical standards 
in the Sigma-Aldrich’s FAME mix (C8–C24) and NIST 
mass spectral library. Fatty acid methyl esters were quan-
tified by peak area. Four replicates were analyzed for each 
sample (obtained from two biological replicates and two 
technical replicates).
Quantitative PCR
Cells were harvested after 36 h of shake flask growth in 
YP medium containing glucose or galactose at 30 °C and 
then mechanically disrupted using acid-washed glass 
beads (425–600 μm) six times in a FastPrep-24 homog-
enizer with 6 m/s beating for 20 s. Total mRNA was then 
extracted using Qiagen’s RNeasy Mini kit. Total mRNA 
(2  µg) was then treated with TURBO DNA-free DNase 
using the TURBO DNA-free kit (Ambion) to remove 
genomic DNA. cDNA was synthesized from mRNA 
using the Bio-Rad’s iScript cDNA synthesis kit. The qPCR 
experiments were carried out using a Roche LightCycler 
480 system with the SsoAdvanced Universal SYBR Green 
Supermix kit (Bio-Rad). Primers were designed using the 
online PrimerQuest tool provided by Integrated DNA 
Technologies and are listed in Additional file 11: Table S2. 
Endogenous actin gene (ACT , RHTO_03560) was used as 
an internal control. All data points were collected from 
three biological replicates.
Aldose reductase cloning and characterization
Cloning and protein expression were performed in 
Escherichia coli strains DH5 and BL21(DE3), respectively. 
E. coli was grown at 37 °C in Luria–Bertani (LB) medium 
(15 g/L yeast extract, 10 g/L tryptone, and 10 g/L NaCl). 
Kanamycin was used at a concentration of 40 μg/mL.
AldR was expressed from a T7 promoter using the 
plasmid pET-28(a). Primers used for this study are listed 
in Additional file  11: Table  S2. R. toruloides IFO0880 
genomic sequence (GenBank: LCTV02000005.1) was 
accessed from National Center for Biotechnology Infor-
mation (http://www.ncbi.nlm.nih.gov), and the aldose 
reductase sequence (Protein Id: 11553 and transcript 
Id: 11681) was accessed from the JGI Genome Portal. 
Aldose reductase sequence was codon optimized by Inte-
grated DNA Technologies for expression in E. coli (Gen-
Bank accession number: MN057734; Additional file  11: 
Table  S3). The overexpression vector was constructed 
first by PCR amplifying the aldose reductase gene aldR 
and then cloning the fragment into pET-28(a) using the 
restriction enzymes BamHI-HF and HindIII-HF with an 
N-terminal  His6-tag.
Escherichia coli BL21 (DE3) containing the aldR gene 
was grown overnight at 37  °C on a rotary shaker at 
250  rpm. The culture was then sub-cultured 1:100 into 
fresh LB medium containing kanamycin and grown at 
37 °C with shaking at 250 rpm until the optical density at 
600 nm reached 0.6–0.8. Aldose reductase expression was 
induced by adding isopropyl-β-d-1-thiogalactopyranoside 
to a final concentration of 0.5  mM. Cells were grown at 
25 °C for additional 16 h at 200 rpm. Cell lysate was soni-
cated six times using 40% amplitude for 20 s on ice. AldR 
lysate was clarified by centrifugation at 13,000×g for 
20  min and then passed through a 0.45  μm filter. AldR 
was purified by loading the lysate onto three 5 mL HiTrap 
Chelating HP columns charged with 0.1  M  NiSO4 and 
installed on an AKTA prime FPLC system (GE Health-
care). The cell-free extract was applied onto a column 
previously equilibrated with binding buffer (50  mM 
 NaH2PO4, 300 mM NaCl, 10 mM imidazole, and pH 8.0). 
The unbound proteins were removed from the column 
with a washing buffer (50 mM  NaH2PO4, 300 mM NaCl, 
30 mM imidazole and pH 8.0). AldR was eluted from the 
column with an elution buffer (50 mM  NaH2PO4, 300 mM 
NaCl, 250 mM imidazole, and pH 8.0). Enzyme fractions 
were analyzed by 10–12% SDS-PAGE (Bio-Rad) and visu-
alized by staining with SimplyBlue SafeStain (Invitrogen). 
Protein concentrations were determined using Coomassie 
Plus (Bradford) assay kit (Pierce). Molecular weight of the 
protein was determined by SDS-PAGE analysis.
Aldose reductase activity was determined spectro-
photometrically (Cary 100 Bio UV–Visible Spectro-
photometer, Agilent) by monitoring the rate of  NADP+ 
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(ε = 5.62 mM−1 cm−1) or NADPH (ε = 5.12 mM−1 cm−1) 
formation at 340  nm. The standard reaction mixture 
(1  mL) contained 20  mM Tris–HCl buffer (pH 7.0), 
10  mM of substrate and an appropriate amount (100–
1000  µg) of the enzyme. The reaction was started by 
adding NAPDPH or  NADP+ to the mixture. One unit of 
aldose reductase activity was defined as the amount of 
enzyme that catalyzes the formation of 1  µmol  NADP+ 
or NAPDPH per minute. The reaction mixture consisted 
of 1  mL 20  mM Tris–HCl buffer with pH 7.5, 10  mM 
NADPH, 10  mM galactose, and purified AldR enzyme. 
After reacting for overnight at 25  °C, the mixture of 
products was centrifuged at 12,000×g for 20 min and the 
supernatant was analyzed by HPLC.
Analysis of intracellular metabolites
For intracellular metabolite analysis, a fast filtration sam-
pling method was used as previously described with a 
slight modification [56]. Briefly, 0.5 mL of culture grown 
until the exponential phase was collected and vacuum 
filtered using a vacuum manifold system (Vac-Man® 
Laboratory Vacuum Manifold, Promega) assembled with 
a nylon membrane filter (0.45 µm pore size, 13 mm diam-
eter, Whatman, Piscataway, NJ, USA) and a filter holder 
(Millipore). The filtered cell culture was then washed with 
2.5 mL of distilled water at room temperature. The entire 
process for fast filtration was finished within 1 min. The 
filter membrane containing the washed cells was quickly 
mixed with 1 mL of a pre-chilled acetonitrile/water mix-
ture (1:1, v/v) and 100 µL of glass beads. The extraction 
mixture was vortexed for 3  min to extract intracellular 
metabolites of R. toruloides IFO0880 by disruption of the 
cell membrane. The extraction mixture was then centri-
fuged at 16,000×g for 3 min at 4 °C. 0.8 mL of superna-
tant containing the intracellular metabolites was dried 
using a speed vacuum concentrator for 6 h.
Prior to GC/MS analysis, intracellular metabolites 
were derivatized by methoxyamination and trimethyl-
silylation. For methoxyamination, 10 µL of 40  mg/
mL methoxyamine chloride in pyridine was added to 
the dried intracellular metabolites and incubated for 
90 min at 30 °C and 200 rpm. The intracellular metab-
olites were then trimethylsilylated by adding 45 µL 
of N-methyl-N-trimethylsilyltrifluoroacetamide for 
30  min at 37  °C and 200  rpm. The derivatized metab-
olite samples were analyzed by GC/MS by an Agilent 
7890A GC/5975C MSD system equipped with an RTX-
5Sil MS capillary column (30  m × 0.25  mm, 0.25  µm 
film thickness; Restek) and an additional 10  m long 
integrated guard column. One microliter of the deri-
vatized sample was injected into the GC in a splitless 
mode. The oven temperature of a GC was initially set 
at 150  °C for 1  min, after which the temperature was 
increased to 330 °C at 20 °C/min, where it was held for 
5 min. The mass spectra were recorded in a scan range 
85–500 m/z at 70 eV of electron impact, and the tem-
perature of the ion source and transfer line was 230 °C 
and 280 °C, respectively.
The raw data obtained from GC/MS analysis were pro-
cessed using an automated mass spectral deconvolution 
and identification system (AMDIS) software for peak 
detection and deconvolution of mass spectra [57]. The 
processed data were uploaded to SpectConnect (http://
spect conne ct.mit.edu) for peak alignment and generat-
ing the data matrix with the Golm Metabolome Data-
base (GMD) mass spectral reference library [58, 59]. The 
normalized abundance values for each metabolite were 
obtained by dividing the peak intensity with the dry cell 
weight. For statistical analysis, such as PCA and hierar-
chical cluster analysis representing as a heat map, the 
ClustVis Web tool was used [60].
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1306 8‑019‑1586‑5.
Additional file 1: Figure S1. HPLC analysis of galactitol production with 
20 g/L of galactose as the carbon source in nitrogen‑rich medium after 
48 h of growth: (a) 10 mM of galactose standard, (b) 10 mM of galactitol 
standard, and (c) 10× diluted test sample (20 g/L of galactose in rich 
medium) after 48 h of growth by R. toruloides IFO0880 showing galactitol 
production. Retention time is plotted on the x‑axis, and galactose and 
galactitol intensities are plotted on the y‑axis. 
Additional file 2: Figure S2. Gas chromatography–mass spectrometry 
analysis of sample peaks. (a) Gas chromatogram showing peaks for galac‑
tose and galactitol, and (b) extracted mass spectra for galactose, and (c) 
extracted mass spectra for galactitol. 
Additional file 3: Figure S3. Proton nuclear magnetic resonance (1H‑
NMR) spectroscopy analysis of galactitol. A total of 4 spectra are shown 
in Figure (all samples were dissolved in 90%  H2O and 10%  D2O). Panel 
(a) contains galactitol as the reference spectrum. Peaks at 3.84 ppm and 
3.55 ppm were observed, noted with * symbol. Panel (b) shows the 1H 
spectrum of the culture media only. No galactitol signals were detected. 
Panel (c) contains the 1H spectrum of the product. The signals from galac‑
titol show up clearly in this spectrum. Panel (d) is the spectrum collected 
after a few mg of galactitol powder were added directly to NMR tube (c). 
The signals from galactitol increased significantly, again indicating that the 
peaks in (c) are from galactitol. 
Additional file 4: Figure S4. Growth of R. toruloides IFO0880 on different 
concentrations of galactitol in nitrogen‑rich medium: (a) effect of galac‑
titol on cell density, (b) utilization of galactitol. Circles, triangles, inverted 
triangles, diamonds are used to denote 0, 1, 5, and 10 g/L galactitol 
concentrations, respectively. 
Additional file 5: Figure S5. Determination of molecular mass of AldR by 
SDS‑PAGE. Lane M: molecular standard marker, Lane UI: uninduced crude 
extract, soluble fraction, Lane I: induced crude extract soluble fraction, and 
Lane P: purified AldR. 
Additional file 6: Figure S6. Characterization of AldR from R. toruloides 
IFO0880 (a) Effect of pH on the activity of AldR. Enzyme assays were car‑
ried out under standard conditions in the presence of 10 mM galactose. 
Assays were carried out in 20 mM citrate buffer (pH 5–6) and 20 mM Tris–
HCl buffer (pH 7–8). Activities at the optimal pH were defined as 100%. (b) 
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Effect of temperature on the activity of AldR. Enzyme assays were carried 
out under standard conditions in the presence of 10 mM galactose in 
20 mM Tris–HCl buffer (pH 7). Activities at the optimal temperature were 
defined as 100%. 
Additional file 7: Figure S7. HPLC analysis of the reaction product 
obtained from in vitro reactions with galactose using AldR. The enzyme 
mixture containing 1 mg/mL AldR, 10 mM galactose, 10 mM NADPH, and 
20 mM Tris–HCl buffer (pH 7.0) was incubated at 25 °C and 200 rpm for 
16 h. 
Additional file 8: Figure S8. A heat map of 29 intracellular metabolites 
in R. toruloides IFO0880 during growth on galactose versus glucose. 
The x‑axis labels represent galactose and glucose as the carbon source, 
and y‑axis labels represent the metabolites. All experiments were per‑
formed in triplicates. 
Additional file 9: Figure S9. Intracellular metabolites present at higher 
concentrations during growth on galactose. The normalized abundance 
levels of the intracellular metabolites in R. toruloides IFO0880 grown on 
galactose (GAL) and glucose (GLC) are shown in box plots. The x‑axis 
labels in the box plots represent the two different carbon sources and 
y‑axis labels in the box plots represent the levels of metabolites. 
Additional file 10: Figure S10. Intracellular metabolites present at higher 
concentrations during growth on glucose. The normalized abundance 
levels of the intracellular metabolites in R. toruloides IFO0880 grown on 
galactose (GAL) and glucose (GLC) are shown in box plots. The x‑axis 
labels in the box plots represent the two different carbon sources and 
y‑axis labels in the box plots represent the levels of metabolites. 
Additional file 11. Tables S1–S5.
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